drugset / Trial / NCT05030272

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings

NCT05030272

RandomizedParallel-groupOpen-labelTreatment

Summary

The study team will conduct a Multisite Randomized Controlled Trial to evaluate the advantages and disadvantages of two approaches for quitting smoking among people with serious mental illness (SMI). The study will compare a novel app tailored to people with SMI, Quit on the Go, to a standard of care smoking cessation intervention. We will test the effectiveness of the Quit on the Go app, an intervention that has demonstrated feasibility and acceptability in the target population, as a tool for smoking cessation in people with SMI. Participants with SMI will be recruited across 3 sites (Duke University, Univ. at Buffalo, and Wake Forest University).

Timeline

Start
2021-09-21
Primary completion
2025-12-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown 2 mg Other
Background Nicotine Unknown 4 mg Other
Background Nicotine Unknown 21 mg Other